Modulating Heat Shock Proteins 70 and 90 Expression by Low Power Laser Irradiation (635nm and 780nm) in Jurkat E6.1 T-lymphocyte Leukemia Cell Line
Journal of Lasers in Medical Sciences,
Vol. 6 No. 1 (2015),
,
Page 17-21
Abstract
Introduction: Heat shock proteins (HSPs) are molecular chaperones involved in protein folding, stability and turnover, and due to their role in cancer progression, the effect of low power laser irradiation (LPLI) on the expression of HSP70 and HSP90 in Jurkat E6.1 T-lymphocyte leukemia (JELT) cell line was investigated in vitro.
Methods: JETL cells were irradiated with LPLI at 635nm and 780m wavelengths (energy density 9.174 J/cm2), and assessed for the expression of HSP70 and HSP90 by flow cytometry after 24, 48 and 72 incubation time periods (ITPs).
Results: At 24 hours ITP post-irradiation, control cultures showed that 10.7% of cells expressed HSP70, while LPLI cultures at 635nm and 780nm manifested a higher expression (32.1and 21.3%, respectively), and the difference was significant (P ≤ 0.05). However, at 48 hours ITP, the three means were decreased but approximated (5.6, 4.9 and 6.2%, respectively), while at 72 hours ITP, they were markedly increased (45.2, 76.5 and 66.7%, respectively). In contrast, HSP90 responded differently to LPLI. At 24 hours ITP, control cultures and 780nm cultures showed a similar expression (55.9 and 55.9%, respectively), but both means were significantly higher than that of 635nm cultures (24.0%). No such difference was observed at 48 hours ITP, and at 72 hours ITP, control cultures and 635nm cultures shared approximated means (31.7 and 35.6%, respectively); but both means were significantly higher than the observed mean in 780nm cultures (15.2%).
Conclusion: The results highlighted that HSP70 and HSP90 expression responded differently to LPLI in JETL cells; an observation that may pave the way for further investigations in malignant cells.
- laser Irradiation
- low-Power
- Jurkat cell
- leukemia cell
- Heat shock proteins
How to Cite
References
Ciocca DR, Fanelli MA, Cuello-Carrion FD, Castro GN. Heat shock proteins in prostate cancer: From tumorigenesis to the clinic. Int J Hyperthermia. 2010; 26:737-47.
Powers MV, Workman P. Inhibitors of heat shock response: biology and pharmacology. FEBS Letters. 2007; 581: 3758-69.
Soo EL, Yip GC, Lwin ZM, Kumar SD, Bay BH. Heat shock proteins as novel therapeutic targets in cancer. In Vivo. 2008; 22:311-6.
Subjeck JR, Repasky EA. Heat shock proteins and cancer therapy: the trail grows hotter. Oncotarget. 2011; 2:433-4.
De Thonel A, Mezger V, Garrido C. Implication of heat shock factors in tumorigenesis: therapeutical potential. Cancers (Basel). 2011; 3:1158-81;
Kapoor C. Vaidya S. Heat shock protein (HSP) and cancer: an overview. Am J Med Dent Sci. 2013; 1: 31-4.
Rylander MN, Feng Y, Bass J, Diller KR. Heat shock protein expression and injury optimization for laser therapy design. Lasers Surg Med. 2007; 39:731-46.
Beckham JT, Mackanos MA, Crooke C, Takahashi T, O’Connell-Rodwell, Contag CH, et al. Assessment of cellular response to thermal laser injury through bioluminescence imaging of heat shock protein 70. Photochem Photobiol. 2004; 79:76-85.
O'Connell-Rodwell CE, Mackanos MA, Simanovskii D, Cao YA, Bachmann MH, Schwettman HA, et al. In vivo analysis of heat-shock-protein-70 induction following pulsed laser irradiation in a transgenic reporter mouse. J Biomed Opt. 2008; 13(3):030501. doi: 10.1117/1.2904665.
Mackanos MA, Contag CH. Pulse duration determines levels of Hsp70 induction in tissues following laser irradiation. J Biomed Opt. 2011; 16(7):078002. doi: 10.1117/1.3600013.
Du S, Zhang Q, Zhang S, Wang L, Lian J. Heat shock protein 70 expression induced by diode laser irradiation on choroid-retinal endothelial cells in vitro. Mol Vis. 2012; 18:2380-7.
Sajjadi AY, Mitra K, Grace M. Expression of heat shock proteins 70 and 47 in tissues following short-pulse laser irradiation: assessment of thermal damage and healing. Med Eng Phys. 2013; 35:1406-14.
Schneider U, Schwenk HU, Bornkamm G. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer. 1977; 19:621-6.
Dempsey NC, Leoni F, Hoyle C, Williams JH. Analysis of heat-shock protein localisation using flow cytometry. Methods Mol Biol. 2011; 787:155-64.
Yamasaki A, Ito H, Yusa J, Sakurai Y, Okuyama N, Ozawa R. Expression of heat shock proteins, Hsp70 and Hsp25, in the rat gingiva after irradiation with a CO2 laser in coagulation mode. J Periodontal Res. 2010;45 :323-30.
Voellmy R, Boellmann F. Chaperone regulation of the heat shock protein response. Adv Exp Med Biol. 2007; 594:89-99.
Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol. 2010; 11:515-28.
Prodromou, C. Strategies for stalling malignancy: targeting cancer's addiction to Hsp90. Curr Top Med Chem. 2009; 9:1352-68.
Giménez Ortiz A, Montalar Salcedo J. Heat shock proteins as targets in oncology. Clin Transl Oncol. 2010; 12:166-73.
Bae JS, Koo NY, Namkoong E, Davies AJ, Choi SK, Shin Y, et al. Chaperone stress 70 protein (STCH) binds and regulates two acid/base transporters NBCe1-B and NHE1. J Biol Chem. 2013; 288:6295-305.
- Abstract Viewed: 250 times
- PDF Downloaded: 140 times
